Chinese Journal of New Drugs - Digital Cluster of Scitech Periodicals

Home>Journals>Chinese Journal of New Drugs

Chinese Journal of New Drugs

CSCD

ISTIC

PKU

ISSN：1003-3734

CN：11-2850/R

Frequency：Semimonthly

Website：http://www.newdrug.cn

Email：bianjibu@newdrug.cn

Postcode：100098

Articles12737

Citations124451

Funded4496

Impact Factor：2.35

Official Website

Articles

2022 No.07

Total 16 articles

Analysis on the patent of rare diseases in China:based on a two-mode network perspectiveLI Shu-xiang, CHU Shu-zhen, YANG Qing

617-623

Prediction of the varieties into drug patent time extended under the background of new patent law in ChinaWANG Yu, GU Dong-lei, CAO Xiao-die, JIAN Yu-cong, PAN Xiao-mei

624-628

Long-term efficacy evaluation of anti-cancer immunotherapyLI Ruo-bing, PAN Jian-hong, HE Juan, YAN Fang-rong

629-634

Clinical trial design of traditional Chinese medicine from the perspective of scientific examinationHAN Fang, LIU Bao-li, CHENG Jin-lian, LIU Qing-quan

635-638

Application of target-organ toxic dose modification of HI method in the assessment of combined exposure to lead, cadmium and arsenic in Polygonatum odoratum ( MilL) DruceZUO Tian-tian, FANG Cui-fen, JIN Hong-yu, WANG Dan-dan, GAO Fei, LI Li, MA Shuang-cheng

639-644

Research progress on quality evaluation methods of chewable tabletsZHU Chun-mei, TENG Jian-hao, ZHANG Meng, WU Hao-xiang

645-654

Research progress of the new triple antibacterial drug Recarbrio in the treatment of complicated intra-abdominal infectionsZHANG Meng, ZHU Chun-mei, TENG Jian-hao, WU Hao-xiang, ZHANG Fu-li

655-663

Bioequivalence of domestic recombinant human growth hormone injections in healthy Chinese volunteersLIU You-ran, WANG Bian-zhen, DONG Li-hou, CHEN Dong-lin, LU Chun-yan, JIN Ji-ting, WANG Li, SUN Xiang-yu, SONG Hai-feng, ZHENG Li

664-668

Qualitative study on the experience of healthy subjects participating the phase Ⅰ drug clinical trialsCHEN Jun-yi, WU Jun-yan, CHEN Jie, YE Sui-wen, MAI Qing-xiu, CHEN Shu-ping

669-674

Discussions on key points of phase Ⅰ clinical trial of injectionDU Dan, LI Feng-shan, YU Qin

675-678